Cargando…
Impact of the PPAR-γ2 Pro12Ala Polymorphism and ACE Inhibitor Therapy on New-Onset Microalbuminuria in Type 2 Diabetes: Evidence From BENEDICT
OBJECTIVE: Cross-sectional studies found less microalbuminuria in type 2 diabetic patients with the Ala12 allele of the peroxisome proliferator–activated receptor-γ2 (PPAR-γ2) Pro12Ala polymorphism. We prospectively evaluated the association between Pro12Ala polymorphism (rs1801282) and new-onset mi...
Autores principales: | De Cosmo, Salvatore, Motterlini, Nicola, Prudente, Sabrina, Pellegrini, Fabio, Trevisan, Roberto, Bossi, Antonio, Remuzzi, Giuseppe, Trischitta, Vincenzo, Ruggenenti, Piero |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
American Diabetes Association
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2780880/ https://www.ncbi.nlm.nih.gov/pubmed/19720797 http://dx.doi.org/10.2337/db09-0407 |
Ejemplares similares
-
Preventing Left Ventricular Hypertrophy by ACE Inhibition in Hypertensive Patients With Type 2 Diabetes: A prespecified analysis of the Bergamo Nephrologic Diabetes Complications Trial (BENEDICT)
por: Ruggenenti, Piero, et al.
Publicado: (2008) -
Effect of Trandolapril on Regression of Retinopathy in Hypertensive Patients with Type 2 Diabetes: A Prespecified Analysis of the Benedict Trial
por: Ruggenenti, Piero, et al.
Publicado: (2010) -
PPARγ2(Pro12Ala) Polymorphism and Human Health
por: He, Weimin
Publicado: (2009) -
PPARγ Pro12Ala and ACE ID polymorphisms are associated with BMI and fat distribution, but not metabolic syndrome
por: Passaro, Angela, et al.
Publicado: (2011) -
Benediction
por: Stewart, George
Publicado: (1943)